Account-creators
1,040
edits
Difference between revisions of "Gene fusion"
Jump to navigation
Jump to search
+cat
Jensflorian (talk | contribs) |
Jensflorian (talk | contribs) (+cat) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 17: | Line 17: | ||
* Whole Genome sequencing (WGS) (Comprehensive and unbiased, but short read length). | * Whole Genome sequencing (WGS) (Comprehensive and unbiased, but short read length). | ||
* [[Immunohistochemistry]] (not suitable/available for all fusions). | * [[Immunohistochemistry]] (not suitable/available for all fusions). | ||
==Examples== | |||
Common fusion in [[Neuropathology]]: | |||
* KIAA1549-BRAF fusion in [[pilocytic astrocytoma]] (up to 70%). | |||
* NAB2-STAT6 fusion in [[Solitary fibrous tumour]]. | |||
* RELA fusion in supratentorial [[ependymoma]] (up to 70% in children). | |||
==See also== | |||
*[[Molecular pathology]]. | |||
*[[Oncogene]]. | |||
[[Category:Molecular pathology]] | |||